Phase 4 Multicenter, Open-label Study on Efficacy and Safety of Apremilast in Moderate-to-severe Psoriasis

NCT07190391 · clinicaltrials.gov ↗
NOT_YET_RECRUITING
Status
425
Enrollment
INDUSTRY
Sponsor class

Conditions

Sponsor

Daewoong Pharmaceutical Co. LTD.